Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis (AD)”

243 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 243 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07184645
What this trial is testing

Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Otsuka Pharmaceutical Co., Ltd. 198
Testing effectiveness (Phase 2)Looking for participantsNCT06855745
What this trial is testing

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Who this might be right for
Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis+3 more
Alphyn Biologics 72
Post-approval studies (Phase 4)UnknownNCT01781663
What this trial is testing

Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Kamedis Ltd. 56
Testing effectiveness (Phase 2)Study completedNCT07712536
What this trial is testing

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07011706
What this trial is testing

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+2 more
Aclaris Therapeutics, Inc. 110
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Not applicableStudy completedNCT03761199
What this trial is testing

Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators

Who this might be right for
Quality of LifeAtopic Dermatitis
University School of Physical Education, Krakow, Poland 24
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Large-scale testing (Phase 3)Study completedNCT05608343
What this trial is testing

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Acrotech Biopharma Inc. 153
Testing effectiveness (Phase 2)Study completedNCT00932074
What this trial is testing

Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Kaken Pharmaceutical 58
Testing effectiveness (Phase 2)Looking for participantsNCT06931990
What this trial is testing

Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT05732454
What this trial is testing

Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Who this might be right for
Atopic DermatitisAtopic Dermatitis, UnspecifiedEczema+1 more
Pfizer 58
Not applicableStudy completedNCT02357940
What this trial is testing

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Who this might be right for
Atopic Dermatitis (AD)
Johnson & Johnson Consumer Inc. (J&JCI) 41
Testing effectiveness (Phase 2)Ended earlyNCT05222516
What this trial is testing

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

Who this might be right for
Atopic Dermatitis
OM Pharma SA 63
Post-approval studies (Phase 4)Study completedNCT04016025
What this trial is testing

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

Who this might be right for
Adherence, PatientChronic Eczema
Jena University Hospital 80
Large-scale testing (Phase 3)Study completedNCT03345914
What this trial is testing

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Regeneron Pharmaceuticals 367
Not applicableStudy completedNCT05517850
What this trial is testing

Therapist-guided vs Self-guided CBT for AD: Non-inferiority Trial

Who this might be right for
Atopic Dermatitis
Karolinska Institutet 168
Post-approval studies (Phase 4)Study completedNCT00510003
What this trial is testing

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)Study completedNCT01979016
What this trial is testing

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis (AD)
Regeneron Pharmaceuticals 54
Next Page